GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (NAS:LMAT) » Definitions » EV-to-EBIT

LeMaitre Vascular (LeMaitre Vascular) EV-to-EBIT

: 33.43 (As of Today)
View and export this data going back to 2006. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, LeMaitre Vascular's Enterprise Value is $1,319.8 Mil. LeMaitre Vascular's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $39.5 Mil. Therefore, LeMaitre Vascular's EV-to-EBIT for today is 33.43.

The historical rank and industry rank for LeMaitre Vascular's EV-to-EBIT or its related term are showing as below:

LMAT' s EV-to-EBIT Range Over the Past 10 Years
Min: 14.27   Med: 27.26   Max: 52.44
Current: 33.43

During the past 13 years, the highest EV-to-EBIT of LeMaitre Vascular was 52.44. The lowest was 14.27. And the median was 27.26.

LMAT's EV-to-EBIT is ranked worse than
74.84% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 19.09 vs LMAT: 33.43

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. LeMaitre Vascular's Enterprise Value for the quarter that ended in Dec. 2023 was $1,181.3 Mil. LeMaitre Vascular's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $39.5 Mil. LeMaitre Vascular's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.34%.


LeMaitre Vascular EV-to-EBIT Historical Data

The historical data trend for LeMaitre Vascular's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 32.64 [6] => 29.97 [7] => 28.68 [8] => 34.57 [9] => 29.93 )
LeMaitre Vascular Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.64 29.97 28.68 34.57 29.93

LeMaitre Vascular Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.57 38.76 50.01 35.95 29.93

Competitive Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular EV-to-EBIT Distribution

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's EV-to-EBIT falls into.



LeMaitre Vascular EV-to-EBIT Calculation

LeMaitre Vascular's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1319.814/39.475
=33.43

LeMaitre Vascular's current Enterprise Value is $1,319.8 Mil.
LeMaitre Vascular's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $39.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LeMaitre Vascular  (NAS:LMAT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

LeMaitre Vascular's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=39.475/1181.312872
=3.34 %

LeMaitre Vascular's Enterprise Value for the quarter that ended in Dec. 2023 was $1,181.3 Mil.
LeMaitre Vascular's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $39.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LeMaitre Vascular EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


LeMaitre Vascular (LeMaitre Vascular) Business Description

Traded in Other Exchanges
Address
63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Executives
George W Lemaitre director, 10 percent owner, officer: Chairman, President and CEO 342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129
Bridget A Ross director C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
John A Roush director C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Lawrence J Jasinski director SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
David B Roberts director, officer: CFO and Director 55 BRADFORD STREET, NEEDHAM MA 02492
Trent G Kamke officer: Senior V. P., Operations 61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132
Martha Shadan director 9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445
Pellegrino Joseph P Jr officer: Executive V.P. Finance 68 BEACON STREET, BOSTON MA 02108
Michael H Thomas director P.O. BOX 2207, NOKOMIS FL 34274-2207
Peter R Gebauer officer: President, International OP AM WALDFELD 17, BAD SODEN 2M 65812
Michael T Wijas officer: VP of Sales, The Americas C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803
Lemaitre Cornelia W director, officer: V.P., Human Resources,Director 8 SUNSET ROCK ROAD, ANDOVER MA 01810
Russell D Hays director C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012
Robert V Linden officer: VP, North American Sales 236 WOODEN BRIDGE ROAD, HOLLAND PA 18966
Thorndike William N Jr director HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199

LeMaitre Vascular (LeMaitre Vascular) Headlines